The recently published HPS2–THRIVE study has shown that the addition of extended release niacin to statin therapy in patients with well-controlled levels of LDL cholesterol does not reduce the risk of ...
High-dose niacin has been previously shown to reduce levels of LDL-cholesterol and increase HDL-cholesterol levels, and thereby maintain a low ratio of total to HDL-cholesterol, which is associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback